SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
143 hedge funds and large institutions have $289M invested in SANGAMO THERAPEUTICS INC in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 19 closing their positions.
287% more call options, than puts
Call options by funds: $4.73M | Put options by funds: $1.22M
37% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 38
11% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 19
1% more funds holding
Funds holding: 141 → 143 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
35% less capital invested
Capital invested by funds: $448M → $289M (-$158M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$8.81M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.7M |
| 3 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
+$3.27M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.38M |
| 5 |
SCM
Sio Capital Management
New York
|
+$2.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$9.1M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.65M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.27M |
| 4 |
CCI
Columbus Circle Investors
|
-$2.61M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$2.4M |
SGMO Hedge Fund Activity: Q1 2016 in Review
143 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2016, worth a combined $289M — down 35% from $448M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new SGMO positions and 19 closed out — a net gain of 2 holders — while 52 added to existing stakes and 38 trimmed.
The largest buyer was Bank of New York Mellon, adding an estimated $8.81M. The largest seller was Millennium Management, cutting an estimated $9.1M.
- 143 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2016, up from 141 in Q4 2015.
- Funds reported $289M of SANGAMO THERAPEUTICS INC stock for Q1 2016, down 35% quarter-over-quarter.
- 21 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2016 and 19 closed out, a net change of +2 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q1 2016 was Bank of New York Mellon, an estimated $8.81M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q1 2016 was Millennium Management, an estimated $9.1M sold.
Based on aggregated 13F filings for Q1 2016.